STEVENSVILLE, Md., Nov. 29 /PRNewswire-USNewswire/ -- Vapotherm, the
global leader in High Flow Oxygen Therapy products, will introduce a new
respiratory care device at the AARC annual conference in Orlando, Florida
on December 1, 2007. Vapotherm's Precision Flow(TM) is the first high flow
therapy device to integrate humidification, gas blending, flow control, and
full alarm functionality into a single device for the delivery of nasal
cannula inspired gases. The company has submitted and is awaiting 510(k)
clearance for the new product from the FDA.
"Vapotherm literally established the High Flow Oxygen Therapy category
and the launch of Precision Flow(TM) not only reinforces our leadership
role in the industry but also illustrates our dedication to developing
innovative respiratory devices that help healthcare professionals improve
the quality of life for their patients," said Robert Storey, President and
CEO of Vapotherm. "The AARC meeting is the ideal venue for us to introduce
the new technology and get valuable feedback from the respiratory
The company's current device, the 2000i, is used in hundreds of
hospitals throughout the US. With Precision Flow(TM), the respiratory
community will have a new option in high flow therapy that includes broader
functionality, additional safety features and ease of use. "We developed
Precision Flow(TM) with extensive input from our respiratory customers and
we believe the device will meet their stated requirements for performance,
safety and cost-effectiveness," said Kevin Thibodeau, Vice President of
Sales and Marketing.
Precision Flow(TM) will be unveiled by Vapotherm at Booth #1337 during
the AARC annual conference in Orlando, Florida in December. The device is
pending FDA 510(k) clearance and is not currently available for sale in the
Vapotherm, Inc. is a privately held manufacturer of respiratory care
devices for hospitals and home care use based in Stevensville, Maryland.
The Company is dedicated to the development of innovative, noninvasive
technologies for respiratory therapy, especially for the treatment of
chronic lung and acute breathing disorders. For more information, visit
Amy Elias/Brian Johnson
SOURCE Vapotherm, Inc.